XML 17 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Operating expenses:    
Research and development $ 989,092 $ 985,751
General and administrative 1,427,793 767,988
Total operating expenses 2,416,885 1,753,739
Loss from operations (2,416,885) (1,753,739)
Other expense:    
Change in fair value of warrant liability (3,000) (2,996,000)
Net loss $ (2,419,885) $ (4,749,739)
Net loss per share, Basic and Diluted $ (0.29) $ (0.81)
Weighted average number of common shares outstanding 8,429,595 5,882,770